BridgeMD
Tests treatment safety and results for Chronic Cough (CC)
Official title Efficacy of Intramuscular Steroid Injection for Chronic Cough.
ClinicalTrials.gov ID: NCT06634823
What this study is testing
What is Triamcinolone Acetonide Injectable Suspension?
Triamcinolone Acetonide Injectable Suspension is an investigational medicine, given as an injection into a muscle, being studied as a potential treatment for chronic cough (cc).
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The primary goal of this study is to test the hypothesis that injecting steroid intramuscularly is an effective treatment for unexplained chronic cough. This will be achieved through the design of a prospective, placebo-controlled, single-blind, randomized clinical trial in which one group of patients will undergo a steroid injection into the deltoid muscle and the second group will undergo a placebo injection into the deltoid muscle.
- Phase 1: an early, usually small safety study
- You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance. You may not know which one you got.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- History consistent with chronic unexplained or refractory cough
- Age ≥ 18
You likely can't join if
- Current smokers
- Uncontrolled diabetes (A1c\>7%)
- Patients on ACE inhibitors or Angiotensin II receptor blockers (ARBs)
- Abnormal pulmonary function testing (PFTs) since start of the cough
- Patients with uncontrolled obstructive sleep apnea
- Abnormal chest X-ray within past 6 months
See the full eligibility criteria
- History consistent with chronic unexplained or refractory cough
- Age ≥ 18
- Current smokers
- Uncontrolled diabetes (A1c\>7%)
- Patients on ACE inhibitors or Angiotensin II receptor blockers (ARBs)
- Abnormal pulmonary function testing (PFTs) since start of the cough
- Patients with uncontrolled obstructive sleep apnea
- Abnormal chest X-ray within past 6 months
- Uncontrolled reflux
- Prior superior laryngeal nerve injection
- Current neuromodulating medication use for chronic cough\
The study team makes the final eligibility decision.
Where it's taking place
- Charleston, South Carolina, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Charleston, South Carolina, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.